Liquidia (LQDA) Receivables - Net (2021 - 2026)
Liquidia (LQDA) recorded quarterly Receivables - Net of $74.2 million in Q1 2026, up 37.09% quarter-over-quarter from $54.1 million in Q4 2025, and up 5846.83% on a YoY basis from $1.2 million in Q1 2025.
Liquidia (LQDA) Receivables - Net (2021 - 2026) Analysis & Trends
Liquidia's Receivables - Net history runs 6 years deep, the most recent figure standing at $74.2 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 5846.83% year-over-year to $74.2 million; the TTM figure through Mar 2026 stood at $74.2 million (up 5846.83% YoY), while the FY2025 annual figure was $54.1 million, up 1889.44% from the prior year.
- Receivables - Net was $74.2 million for Q1 2026 at Liquidia, up from $54.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $74.2 million in Q1 2026 to a low of $1.2 million in Q1 2025.
- Historically, Receivables - Net has averaged $12.9 million across 5 years, with a median of $4.1 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Receivables - Net tumbled 51.48% in 2025, then surged 5846.83% in 2026.
- A 5-year view of Receivables - Net shows it stood at $5.0 million in 2022, then dropped by 19.06% to $4.1 million in 2023, then plunged by 33.05% to $2.7 million in 2024, then soared by 1889.44% to $54.1 million in 2025, then soared by 37.09% to $74.2 million in 2026.
- The last three Receivables - Net figures came in at $74.2 million (Q1 2026), $54.1 million (Q4 2025), and $36.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.16 Mn |
| Mar 31, 2026 | 74.16 Mn |
| Dec 31, 2025 | 54.09 Mn |
| Dec 31, 2025 | 54.09 Mn |
| Sep 30, 2025 | 35.96 Mn |
| Sep 30, 2025 | 35.96 Mn |
| Jun 30, 2025 | 9.97 Mn |
| Jun 30, 2025 | 9.97 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Dec 31, 2023 | 4.06 Mn |